• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.由备解素途径的D因子和B因子与眼镜蛇毒因子或C3B相互作用产生的趋化活性。
J Clin Invest. 1975 Mar;55(3):587-92. doi: 10.1172/JCI107966.
2
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.膜增生性肾小球肾炎和同种异体移植排斥反应中补体激活途径。
Transplant Proc. 1977 Mar;9(1):729-39.
3
Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.通过备解素途径在人血清中裂解第三补体成分(C3)并生成致痉肽C3a:ε-氨基己酸抑制和增强作用的证明
J Immunol. 1975 Feb;114(2 Pt 1):671-7.
4
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.备解素系统C3激活酶复合物的形成与组成。其组分在固相胰蛋白酶-琼脂糖上的顺序组装。
Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(5):440-55.
5
Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.单纯疱疹病毒糖蛋白C使补体失活的机制。
J Immunol. 1997 Feb 15;158(4):1763-71.
6
Properdin: initiation of alternative complement pathway.备解素:替代补体途径的起始因子
Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4. doi: 10.1073/pnas.72.8.3220.
7
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.风湿性疾病中的C3b灭活剂。通过放射免疫扩散法以及对备解素途径C3转化酶形成的抑制作用进行测量。
J Clin Invest. 1976 Jun;57(6):1554-63. doi: 10.1172/JCI108426.
8
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.C3肾炎因子(C3NeF):液相和细胞结合的替代途径转化酶的稳定作用。
J Immunol. 1976 Jan;116(1):1-7.
9
Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.精子产生中性粒细胞趋化因子:补体的作用及精浆因子的调节
J Immunol. 1976 Oct;117(4):1378-86.
10
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.补体替代途径:不稳定的C3/C5转化酶招募前体备解素并增强该途径。
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.

引用本文的文献

1
Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.人补体成分1灭活剂对中性粒细胞趋化性及趋化失活的影响
Infect Immun. 1980 Jun;28(3):700-7. doi: 10.1128/iai.28.3.700-707.1980.
2
Chemotactic responses of various differentiational stages of neutrophils from human cord and adult blood.来自人类脐带血和成人血液的中性粒细胞不同分化阶段的趋化反应。
Infect Immun. 1982 Mar;35(3):921-8. doi: 10.1128/iai.35.3.921-928.1982.
3
The human eosinophil: roles in host defense and tissue injury.人类嗜酸性粒细胞:在宿主防御和组织损伤中的作用。
Am J Pathol. 1980 Sep;100(3):791-820.
4
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.金黄色葡萄球菌和铜绿假单胞菌释放的趋化因子对小鼠呼吸道的影响。
Infect Immun. 1985 Aug;49(2):265-9. doi: 10.1128/iai.49.2.265-269.1985.
5
Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors.内毒素诱导兔多形核白细胞对内源性趋化因子反应的选择性功能障碍。
Infect Immun. 1985 Nov;50(2):527-33. doi: 10.1128/iai.50.2.527-533.1985.
6
Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis.特应性皮炎中单核细胞和多形核白细胞趋化功能缺陷及临床特征
Arch Dermatol Res. 1986;278(6):454-9. doi: 10.1007/BF00455163.
7
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.备解素系统成分与培养的人淋巴母细胞和B淋巴细胞的结合。
J Exp Med. 1976 Feb 1;143(2):271-89. doi: 10.1084/jem.143.2.271.
8
Modulation of human eosinophil polymorphonuclear leukocyte migration and function.人类嗜酸性多形核白细胞迁移和功能的调节
Am J Pathol. 1976 Nov;85(2):419-36.
9
Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide.眼镜蛇毒因子制剂中的磷脂酶A2污染。在补体依赖性体内反应中的生物学作用以及对溴苯甲酰溴的灭活作用。
Am J Pathol. 1978 Jun;91(3):517-30.

本文引用的文献

1
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.血清补体在体外白细胞趋化性中的作用
J Exp Med. 1965 Aug 1;122(2):327-46. doi: 10.1084/jem.122.2.327.
2
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
3
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.源自人补体第二和第四成分的分子复合物的形成及其功能意义。
J Exp Med. 1967 Feb 1;125(2):359-80. doi: 10.1084/jem.125.2.359.
4
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.豚鼠血清中溶血补体九种成分的分离、纯化及测定方法
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
5
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.人C3灭活剂。I. 通过细胞结合C3的灭活进行溶血测定。
J Immunol. 1969 Mar;102(3):533-43.
6
A neutrophil chemotactic factor from human C'5.一种源自人补体C5的嗜中性粒细胞趋化因子。
J Immunol. 1969 Jan;102(1):93-9.
7
The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.趋化因子对兔中性粒细胞的失活作用及可激活酯酶的性质。
J Exp Med. 1968 Apr 1;127(4):693-709. doi: 10.1084/jem.127.4.693.
8
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.激肽释放酶原的一种前清蛋白激活剂。3. 人激肽释放酶原转化为激肽释放酶后出现对人中性粒细胞的趋化活性。
J Exp Med. 1972 Jan;135(1):81-97. doi: 10.1084/jem.135.1.81.
9
Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.人类补体第二成分(C2)的遗传性缺陷:C2溶血活性与C2蛋白免疫化学测量的相关性。
Immunology. 1970 Jun;18(6):943-54.
10
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.眼镜蛇毒中的两种抗补体因子:其中一种可使豚鼠红细胞发生溶血。
J Immunol. 1969 Nov;103(5):944-52.

由备解素途径的D因子和B因子与眼镜蛇毒因子或C3B相互作用产生的趋化活性。

Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

作者信息

Ruddy S, Austen K F, Goetzl E J

出版信息

J Clin Invest. 1975 Mar;55(3):587-92. doi: 10.1172/JCI107966.

DOI:10.1172/JCI107966
PMID:1167871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC301787/
Abstract

Interaction of D (the activated form of D) and B, factors of the properdin pathway, with C3b (the major cleavage fragment of C3) generates a convertase, C3B, which cleaves C3 and initiates the terminal complement sequence C5-C9. A functionally analogous more stable C3 convertase, CoVFB, ir formed by substituting cobra venom factor (CoVF) for C3b. Mixtures of highly purified CoVF, B, and D were chemotactic for human neutrophil polymorphonuclear leukocytes as assessed in Boyden chambers either by microscopic enumeration of migrating cells or by counting of 51Cr-labeled cells. Control mixtures containing CoVF, B, and D, reacted in the absence of Mg++, were hemolytically inactive and devoid of chemotactic activity. Over a range of doses, the chemotactic activity of mixtures yielding CoVFB correlated with their hemolytic activity. Pretreatment of neutrophils with mixtures containing CoVFB rendered them unresponsive to subsequent chemotactic stimulation by kallikrein of C5a, indicating cross-deactivation to other chemotactic factors. Similar neutrophil deactivation occurred after exposure to a mixture of C3b, B, and D in which C3B was formed; with short incubation times and high cell concentration C3B also exhibited some chemotactic activity. The chemotactic activity of C3B and CoVFB is an example of a biologic function arising from interactions among factors of the properdin pathway per se, as distinguished from the capacity of this pathway to activate C3 and the terminal complement sequence.

摘要

补体旁路途径中的D(D的活化形式)和B因子与C3b(C3的主要裂解片段)相互作用产生一种转化酶C3B,它裂解C3并启动终末补体序列C5 - C9。一种功能类似但更稳定的C3转化酶CoVFB,是通过用眼镜蛇毒因子(CoVF)替代C3b形成的。在Boyden小室中,通过显微镜计数迁移细胞或计数51Cr标记的细胞评估,高度纯化的CoVF、B和D的混合物对人中性粒细胞多形核白细胞具有趋化作用。不含Mg++时反应的含CoVF、B和D的对照混合物无溶血活性且无趋化活性。在一系列剂量范围内,产生CoVFB的混合物的趋化活性与其溶血活性相关。用含CoVFB的混合物预处理中性粒细胞,使其对随后激肽释放酶或C5a的趋化刺激无反应,表明对其他趋化因子存在交叉失活。暴露于形成C3B的C3b、B和D的混合物后,中性粒细胞也会发生类似的失活;在短孵育时间和高细胞浓度下,C3B也表现出一定的趋化活性。C3B和CoVFB的趋化活性是补体旁路途径因子本身相互作用产生的生物学功能的一个例子,这与该途径激活C3和终末补体序列的能力不同。